ICD stands for “implantable cardioverter-defibrillator.” A doctor places it under the skin. It has wires that run to the heart. They are used to:
- Prevent death from cardiac arrest.
- Help patients with heart rhythm problems.
At UK HealthCare, we report placement data to the ICD Registry. This allows us to compare patient data with other hospitals nationally. It is also a measure of our quality of care.
Below are three sets of data (metrics) on ICD patients.
Data Source: The American College of Cardiology’s ICD Registry® University of Kentucky Institutional Outcomes Report for Quarter three 2015. The ICD Registry is the only nationwide outcomes-based quality improvement program for hospitals performing implantable cardioverter- defibrillator procedure. There were 1521 US Hospitals submitting data to the ICD Registry in quarter three 2015.
There are recommended guidelines for the use of ICDs. They are based on research. The guidelines weigh the benefits and risks of ICD placement. Here are the guidelines for appropriate treatment:
- Class I: The benefits significantly outweigh the risks. ICD should be placed.
- Class IIa: The benefits outweigh the risks. It is reasonable to place the ICD.
- Class IIb: The benefits are equal to or greater than the risks. Placing an ICD may be considered.
This graph shows the patients that received an ICD for classes I, IIa and IIb in 2015. A higher number is better. The average performance for U.S. hospitals reporting to ICD Registry is 92%. Our score is 96.9.
Risk-Adjusted Complications is a set of data that shows the number of deaths or related health problems for ICD patients. It looks at the time frame from implantation to discharge. The data takes into account each patient’s health problem.
Here, a lower score is better. The average performance for U.S. hospitals reporting to ICD Registry is 1.39% Risk-Adjusted Complication rate. Our number is .86%.
Studies show that ICD patients do better when they take the right medicines at home. Three medicines recommended for ICD patients are ACE inhibitors (angiotensin converting enzyme inhibitors), ARBs (angiotensin receptor blockers), and beta blockers.
This graph shows what part of the eligible patients receive these medicines on discharge. A higher number is better. This compares us to all U.S. hospitals reporting to the ICD Registry. The average performance for U.S. hospitals reporting to ICD Registry is 82.8%. Our performance in this metric is 90%.